Showing results (551-560 of 827) with videos related to
Sort By:
Pageof 83
P & T : a Peer-Reviewed Journal for Formulary Management|July 14, 2016
HHS Walks the Middle Ground in Final Ruling on Nondiscrimination: Drug Access and Formulary Construction Still UnguidedStephen BarlasP & T : a Peer-Reviewed Journal for Formulary Management|July 14, 2016
Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive DisorderShannon Eaves, Jose A ReyP & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
Small Effort, Big Payoff: Automated Maximum Dose Alerts With Hard StopsMatthew GrissingerP & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
Do SSRI Antidepressants Increase The Risk of Extrapyramidal Side Effects In Patients Taking Antipsychotics?Matthew Allsbrook, Brant E Fries, Kristina L Szafara, et al.P & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
American Society of Hematology 2015 Annual MeetingWalter AlexanderP & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
Pharmaceutical Approval UpdateChris FellnerP & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese AdultsMatthew M Sherman, Sinziana Ungureanu, Jose A ReyP & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
The Checkpoint Immunotherapy Revolution: What Started as a Trickle Has Become a Flood, Despite Some Daunting Adverse Effects; New Drugs, Indications, and Combinations Continue to EmergeWalter AlexanderP & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
American Academy of Ophthalmology 2015 Annual MeetingPeter Sonnenreich, Janice ZoellerP & T : a Peer-Reviewed Journal for Formulary Management|December 18, 2014
Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infectionsMaria Sorbera, Elizabeth Chung, Christopher W Ho, et al.Pageof 83